Results 211 to 220 of about 73,620 (322)
Risk-stratified treatment of sonrotoclax with chemotherapy in newly diagnosed acute myeloid leukemia: a study protocol. [PDF]
Zhang Y+12 more
europepmc +1 more source
Cytogenetic Studies in <i>Avena</i>, XII
Ichizo Nishiyama, Mamoru Tabata
openalex +2 more sources
Summary IKZF1 mutations are recurrent alterations in acute myeloid leukaemia (AML), and hotspot point mutation, N159S, has recently been associated with unique gene expression and adverse risk. To better understand the molecular and clinical associations of IKZF1 N159S‐mutated AML, we performed a pooled analysis of 4136 AML patients.
Sebastian Stasik+18 more
wiley +1 more source
High variability in chromosome number from a clade within the gourami family (Teleostei, Osphronemidae). [PDF]
Mobley B, Anderson AP.
europepmc +1 more source
Are we ignoring sex differences in haematological malignancies? A call for improved reporting
A large body of data indicates that there are sex differences in the incidence of haematological malignancies, their clinical presentation and molecular profiles, and possibly also their aetiologies. Furthermore, sex‐related differences exist in treatment tolerability and outcomes.
Ora Paltiel+2 more
wiley +1 more source
Cytogenomic characterization of mosaic X-ring chromosomes in seventeen patients with Turner syndrome (TS)-42 years of experience at a single-site institution. [PDF]
Madison A+7 more
europepmc +1 more source
Cytogenetical study in Spalax leucodon Nordm. in Moldavia (Rumania) [PDF]
P. Raicu, Doina Duma
openalex +1 more source
Therapeutic drug monitoring (TDM) of imatinib is reported from a real‐world study in 66 children with paediatric Chronic Myeloid Leukemia (pCML). TDM allows dose adjustments, improving molecular response rates and is a step forward in personalized pCML care.
Meinolf Suttorp+8 more
wiley +1 more source
Clinical benefit loss in myeloma patients declining autologous stem cell transplantation: a real-world study. [PDF]
Wang Y+5 more
europepmc +1 more source